» Authors » Thais F Conti

Thais F Conti

Explore the profile of Thais F Conti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 142
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cao J, Conti T, Hom G, Babiuch A, Greenlee T, Ehlers J, et al.
J Vitreoretin Dis . 2023 Apr; 4(4):286-292. PMID: 37009186
Purpose: This article characterizes widefield fundus autofluorescence (WF-FAF) patterns in retinoschisis (RS), retinal detachment (RD), and combined retinoschisis-detachment (RS/RD), and to correlate them with spectral-domain optical coherence tomography (SD-OCT) findings....
2.
Golshani C, Conti T, Conti F, Silva F, Rachitskaya A, Yuan A, et al.
J Vitreoretin Dis . 2023 Apr; 4(5):364-371. PMID: 37008295
Purpose: This article reports 12-month outcomes of patients with diabetic macular edema previously treated with other antivascular endothelial growth factor agents and transitioned to fixed dosing of intravitreal aflibercept (IAI)....
3.
Hom G, Kuo B, Ross J, Chapman G, Sharma N, Sastry R, et al.
Can J Ophthalmol . 2023 Mar; 59(2):128-136. PMID: 36878265
Objective: Pentosan polysulfate (PPS; ELMIRON, Janssen Pharmaceuticals, Titusville, NJ) is a U.S. Food and Drug Administration-approved oral medication for interstitial cystitis. Numerous reports have been published detailing retinal toxicity with...
4.
Muste J, Russell M, Chen A, Seth K, Iyer A, Valentim C, et al.
Ophthalmic Surg Lasers Imaging Retina . 2023 Jan; 54(1):24-31. PMID: 36626211
Purpose: Oxidative stress-induced mitochondrial dysfunction is implicated in the pathogenesis of age-related macular degeneration (AMD). Oxidized mitochondrial flavoprotein fluorescence (FPF) may serve as a quantifiable biomarker of oxidative stress, reported...
5.
Greenlee T, Malhotra N, Iyer A, Conti T, Chen A, Singh R
Ophthalmic Surg Lasers Imaging Retina . 2022 Jul; 53(7):380-391. PMID: 35858229
Background And Objective: This study characterizes the impact of race, ethnicity, insurance status, and geographic location on anti-vascular endothelial growth factor (VEGF) use for the treatment of diabetic macular edema...
6.
Malhotra N, Muste J, Hom G, Conti T, Greenlee T, Singh R
Ophthalmic Surg Lasers Imaging Retina . 2021 Nov; 52(11):578-585. PMID: 34766853
Background And Objective: Although people of low socioeconomic status (SES) and certain racial groups are at greater risk of developing diabetic macular edema (DME), the extent these high-risk groups experience...
7.
Owen J, Blazes M, Manivannan N, Lee G, Yu S, Durbin M, et al.
Biomed Opt Express . 2021 Oct; 12(9):5387-5399. PMID: 34692189
This work explores a student-teacher framework that leverages unlabeled images to train lightweight deep learning models with fewer parameters to perform fast automated detection of optical coherence tomography B-scans of...
8.
Han M, Hsueh J, Chen A, Greenlee T, Conti T, Rose S, et al.
J Patient Exp . 2021 Aug; 8:23743735211033750. PMID: 34395846
The purpose of the current study is to examine how nonmodifiable sociodemographic, disease, appointment, management, and survey factors correlate with provider rating. This was a retrospective cross-sectional study conducted on...
9.
Chen E, Chen A, Greenlee T, Conti T, Briskin I, Urbano C, et al.
Can J Ophthalmol . 2021 Jul; 57(5):350-356. PMID: 34283969
Objective: To establish whether increased variability in macular thickness in neovascular age-related macular degeneration (nAMD) patients affects visual outcomes in clinical practice DESIGN: Retrospective cohort study PARTICIPANTS: Treatment-naive nAMD patients...
10.
Wang V, Kuo B, Chen A, Wang K, Greenlee T, Conti T, et al.
Eye (Lond) . 2021 Jul; 36(7):1461-1467. PMID: 34234291
Purpose: To evaluate retinal thickness fluctuations in patients with diabetic macular oedema (DMO) treated with anti-vascular endothelial growth factor (anti-VEGF) injections. Methods: Visual acuity (VA) and central subfield thickness (CST)...